Rapid Dose Therapeutics Corp. logo

Rapid Dose Therapeutics Corp. (DOSE)

Market Closed
12 Dec, 20:00
CNSX CNSX
CA$
0. 16
+0.01
+3.23%
CA$
34.51M Market Cap
- P/E Ratio
0% Div Yield
32,500 Volume
- Eps
CA$ 0.15
Previous Close
Day Range
0.14 0.16
Year Range
0.13 0.27
Want to track DOSE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 44 days

Summary

DOSE closed Friday higher at CA$0.16, an increase of 3.23% from Thursday's close, completing a monthly increase of 3.23% or CA$0.01. Over the past 12 months, DOSE stock lost -27.27%.
DOSE is not paying dividends to its shareholders.
The last earnings report, released on Oct 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jan 27, 2026.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on CNSX (CAD).

DOSE Chart

Similar

Gemina Laboratories Ltd.
CA$ 0.13
0%
Telescope Innovations Corp.
CA$ 0.33
-2.94%
Unidoc Health Corp.
CA$ 0.18
0%
XTM Inc.
CA$ 0.02
+33.33%
PharmaTher Holdings Ltd.
CA$ 0.11
-4.35%

Rapid Dose Therapeutics Corp. (DOSE) FAQ

What is the stock price today?

The current price is CA$0.16.

On which exchange is it traded?

Rapid Dose Therapeutics Corp. is listed on CNSX.

What is its stock symbol?

The ticker symbol is DOSE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 34.51M.

When is the next earnings date?

The next earnings report will release on Jan 27, 2026.

Has Rapid Dose Therapeutics Corp. ever had a stock split?

No, there has never been a stock split.

Rapid Dose Therapeutics Corp. Profile

Biotechnology Industry
Healthcare Sector
Mr. Mark Andrew Upsdell CEO
CNSX Exchange
- ISIN
CA Country
- Employees
- Last Dividend
16 Feb 2018 Last Split
- IPO Date

Overview

Rapid Dose Therapeutics Corp. is a pioneering life sciences company based in Burlington, Canada, specializing in innovative drug delivery technologies. The company is committed to improving health outcomes by providing advanced solutions for the rapid release of active molecules into the bloodstream. Their target market encompasses the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries, for whom they also offer product innovation, production, and consultation services. Through its cutting-edge approach, Rapid Dose Therapeutics aims to enhance the bioavailability of medications, resulting in faster and more efficient drug absorption.

Products and Services

  • QuickStrip/PharmaStrip: An oral, fast-dissolving drug delivery system designed to rapidly release pharmaceuticals, emulsified oils, and over-the-counter medicines into the bloodstream. This technology improves the efficiency and onset of action for various drugs, offering a convenient alternative to traditional delivery methods.
  • QuickStrip Energy: A specialized strip that delivers an energizing dose of caffeine quickly into the system. It's formulated for those in need of a quick energy boost without the inconvenience of consuming beverages or pills.
  • QuickStrip B12: This product is designed to efficiently deliver vitamin B12 directly into the bloodstream, providing an innovative solution for individuals requiring supplementation, particularly those with dietary restrictions or absorption issues.
  • QuickStrip Sleep: A melatonin-based product aimed at enhancing sleep quality. QuickStrip Sleep allows for the rapid delivery of melatonin into the bloodstream, aiding in the reduction of the time taken to fall asleep.
  • Dental Products: Rapid Dose Therapeutics also ventures into oral health, providing fast-dissolving strips that target dental concerns, contributing to overall oral hygiene and health.
  • Consultation Services: Beyond product offerings, the company extends its expertise through product innovation, production, and consultation services to industries such as nutraceuticals, cannabis healthcare, and pharmaceuticals. These services are designed to help other organizations innovate and enhance their own product lines using Rapid Dose Therapeutics' advanced delivery technologies.

Contact Information

Address: 1121 Walkers Line
Phone: 416 477 1052